<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02683031</url>
  </required_header>
  <id_info>
    <org_study_id>#0010010</org_study_id>
    <nct_id>NCT02683031</nct_id>
  </id_info>
  <brief_title>Effect of Ca2+ Ionophore on Embryonic Development and Clinical Outcome in Cases With Previous Fertilization Arrest</brief_title>
  <official_title>A Prospective Randomized Controlled Trial Investigating Embryonic Development and Clinical Outcome After Using Ca2+ Ionophore in Cases With Previous Fertilization Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TopLab Company for ART Laboratories Consultation and Training</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>TopLab Company for ART Laboratories Consultation and Training</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aimed to investigate the efficiency of chemical oocyte activation using readymade Ca2+
      ionophore on cases with previously cancelled cases due to fertilization arrest at pronuclear
      stage i.e: cleavage failure to find out if there is any improvement in embryonic
      developmental stages.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many studies reported that Ca2+ ionophore has a positive effect on embryo development in
      cases with complete or partial fertilization failure. However, only one preliminary report
      suggested a beneficial effect of Ca2+ ionophore activation in four cases with fertilization
      arrest.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blastocyst formation rate</measure>
    <time_frame>5 to 7days post oocyte retrival</time_frame>
    <description>Defined as the total number of blastocyst / total number of cleaved Embryos</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Fertilization Arrest</condition>
  <arm_group>
    <arm_group_label>Without Ca2+ ionophore</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with previous incomplete ICSI cycle due to fertilization arrest were counseled to underwent a subsequent conventional ICSI cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>With Ca2+ ionophore</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with previous incomplete ICSI cycle due to fertilization arrest were counseled to underwent a subsequent ICSI cycle combined with artificial oocyte activation using Ca2+ ionophore.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ca2+ ionophore</intervention_name>
    <description>Ca2+ ionophore is a chemical agent used to perform oocyte activation after ICSI. It showed effective treatment to get better fertilization, pregnancy, and healthy livebirth in cases with total or partial fertilization failure.</description>
    <arm_group_label>With Ca2+ ionophore</arm_group_label>
    <other_name>A23187 Ca2+ ionophore</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with previous history of complete fertilization arrest.

          -  ovarian stimulation with the GnRH agonist and recombinant FSH in a long protocol.

        Exclusion Criteria:

          -  Female age &gt;40 years
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasmin Magdi, M.Sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dar Almaraa fertility and gynacology center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mona M. Awady, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Community Medicine, Faculty of Medicine, Benha University, Benha, Egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yasmin Magdi, M.Sc</last_name>
    <phone>+201282313979</phone>
    <email>Yas.magdi@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed El-Damen, M.Sc</last_name>
    <phone>+201002414342</phone>
    <email>Ahmed_eldamen@Yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ahmed el-Damen</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed El-Damen</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Ebner T, Köster M, Shebl O, Moser M, Van der Ven H, Tews G, Montag M. Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertil Steril. 2012 Dec;98(6):1432-7. doi: 10.1016/j.fertnstert.2012.07.1134. Epub 2012 Aug 24.</citation>
    <PMID>22921909</PMID>
  </reference>
  <reference>
    <citation>Ebner T, Montag M; Oocyte Activation Study Group, Montag M, Van der Ven K, Van der Ven H, Ebner T, Shebl O, Oppelt P, Hirchenhain J, Krüssel J, Maxrath B, Gnoth C, Friol K, Tigges J, Wünsch E, Luckhaus J, Beerkotte A, Weiss D, Grunwald K, Struller D, Etien C. Live birth after artificial oocyte activation using a ready-to-use ionophore: a prospective multicentre study. Reprod Biomed Online. 2015 Apr;30(4):359-65. doi: 10.1016/j.rbmo.2014.11.012. Epub 2014 Dec 9.</citation>
    <PMID>25596904</PMID>
  </reference>
  <results_reference>
    <citation>Darwish E, Magdi Y. A preliminary report of successful cleavage after calcium ionophore activation at ICSI in cases with previous arrest at the pronuclear stage. Reprod Biomed Online. 2015 Dec;31(6):799-804. doi: 10.1016/j.rbmo.2015.08.012. Epub 2015 Aug 28.</citation>
    <PMID>26507280</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2016</study_first_submitted>
  <study_first_submitted_qc>February 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2016</study_first_posted>
  <last_update_submitted>August 17, 2016</last_update_submitted>
  <last_update_submitted_qc>August 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dar AlMaraa Center</investigator_affiliation>
    <investigator_full_name>Yasmin Magdi</investigator_full_name>
    <investigator_title>Senior clinical embryologist</investigator_title>
  </responsible_party>
  <keyword>fertilization arrest</keyword>
  <keyword>Cleavage failure</keyword>
  <keyword>Embryonic development</keyword>
  <keyword>Calcium ionophore</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infliximab</mesh_term>
    <mesh_term>Ionophores</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

